Omid Mehdizadeh
NPI 1770816464 · Otolaryngology Physician · Santa Monica, CA
Enrolled with Medicare as Practitioner - Otolaryngology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1770816464
- Entity type
- Individual
- Primary specialty
- Otolaryngology PhysicianAllopathic & Osteopathic Physicians
- Sex
- Male
- Sole proprietor
- No
- License
- 150014 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
16 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,980 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 487 | $139 |
| Removal of Impacted Ear Wax69210 | 241 | $48 |
| Exam to Assess Movement of Vocal Cord Flaps Using an Endoscope31579 | 227 | $216 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 201 | $99 |
| Analysis of Voice and Resonance Production92524 | 183 | $117 |
| Diagnostic Exam of Voice Box Using a Flexible Endoscope31575 | 168 | $144 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 17 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Famotidine | 123 | 59 |
| Ipratropium Bromide | 116 | 47 |
| Fluticasone Propionate | 98 | 53 |
| Pantoprazole Sodium | 91 | 54 |
| Azelastine Hcl | 56 | 30 |
| Amoxicillin/Potassium Clavbrand: Amoxicillin-Clavulanate Potass | 48 | 44 |
| Mupirocin | 38 | 34 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$710 across 15 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2009-09-12
- Last updated
- 2022-05-16
- Certified
- 2022-05-16
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.